These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10796782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Newborn screening for cystic fibrosis.
    Merelle ME, Nagelkerke AF, Lees CM, Dezateux C.
    Cochrane Database Syst Rev; 2001; (3):CD001402. PubMed ID: 11686989
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Omega-3 fatty acids (from fish oils) for cystic fibrosis.
    Beckles Willson N, Elliott TM, Everard ML.
    Cochrane Database Syst Rev; 2002; (3):CD002201. PubMed ID: 12137649
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral calorie supplements for cystic fibrosis.
    Smyth R, Walters S.
    Cochrane Database Syst Rev; 2000; (2):CD000406. PubMed ID: 10796716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic antibiotics for cystic fibrosis.
    Smyth A, Walters S.
    Cochrane Database Syst Rev; 2000; (2):CD001912. PubMed ID: 10796836
    [Abstract] [Full Text] [Related]

  • 12. Interventions for treating femoral shaft fractures in children and adolescents.
    Madhuri V, Dutt V, Gahukamble AD, Tharyan P.
    Evid Based Child Health; 2014 Dec; 9(4):753-826. PubMed ID: 25504970
    [Abstract] [Full Text] [Related]

  • 13. Oral steroids for cystic fibrosis.
    Cheng K, Ashby D, Smyth R.
    Cochrane Database Syst Rev; 2000 Dec; (2):CD000407. PubMed ID: 10796717
    [Abstract] [Full Text] [Related]

  • 14. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML.
    Pediatrics; 2001 Jan; 107(1):1-13. PubMed ID: 11134427
    [Abstract] [Full Text] [Related]

  • 15. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S, Dezateux C, Kavanagh J, Lempert T, Stewart R.
    Cochrane Database Syst Rev; 2004 Oct 18; 2004(4):CD003859. PubMed ID: 15495068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
    Elkins MR, Jones A, Schans C.
    Cochrane Database Syst Rev; 2004 Oct 18; (1):CD003147. PubMed ID: 14974007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ursodeoxycholic acid for cystic fibrosis-related liver disease.
    Cheng K, Ashby D, Smyth R.
    Cochrane Database Syst Rev; 2000 Oct 18; (2):CD000222. PubMed ID: 10796703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.